Immunological hallmarks of stromal cells in the tumour microenvironment
- PMID: 26471778
- DOI: 10.1038/nri3902
Immunological hallmarks of stromal cells in the tumour microenvironment
Abstract
A dynamic and mutualistic interaction between tumour cells and the surrounding stroma promotes the initiation, progression, metastasis and chemoresistance of solid tumours. Far less understood is the relationship between the stroma and tumour-infiltrating leukocytes; however, emerging evidence suggests that the stromal compartment can shape antitumour immunity and responsiveness to immunotherapy. Thus, there is growing interest in elucidating the immunomodulatory roles of the stroma that evolve within the tumour microenvironment. In this Review, we discuss the evidence that stromal determinants interact with leukocytes and influence antitumour immunity, with emphasis on the immunological attributes of stromal cells that may foster their protumorigenic function.
Similar articles
-
Classification and biology of tumour associated stromal cells.Immunol Lett. 2015 Dec;168(2):175-82. doi: 10.1016/j.imlet.2015.06.016. Epub 2015 Jul 2. Immunol Lett. 2015. PMID: 26145459 Review.
-
Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?Cancer Immunol Res. 2016 Apr;4(4):269-78. doi: 10.1158/2326-6066.CIR-16-0011. Cancer Immunol Res. 2016. PMID: 27036971 Free PMC article. Review.
-
The tumour microenvironment and implications for cancer immunotherapy.Expert Opin Biol Ther. 2006 Jul;6(7):671-84. doi: 10.1517/14712598.6.7.671. Expert Opin Biol Ther. 2006. PMID: 16805707 Review.
-
Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.J Urol. 2005 Jan;173(1):10-20. doi: 10.1097/01.ju.0000141582.15218.10. J Urol. 2005. PMID: 15592017 Review.
-
Metabolic reprogramming of the tumour microenvironment.FEBS J. 2015 Oct;282(20):3892-8. doi: 10.1111/febs.13402. Epub 2015 Aug 25. FEBS J. 2015. PMID: 26255648 Review.
Cited by
-
HSPD1 Supports Osteosarcoma Progression through Stabilizing ATP5A1 and thus Activation of AKT/mTOR Signaling.Int J Biol Sci. 2024 Sep 23;20(13):5162-5190. doi: 10.7150/ijbs.100015. eCollection 2024. Int J Biol Sci. 2024. PMID: 39430254 Free PMC article.
-
Cold and hot tumors: from molecular mechanisms to targeted therapy.Signal Transduct Target Ther. 2024 Oct 18;9(1):274. doi: 10.1038/s41392-024-01979-x. Signal Transduct Target Ther. 2024. PMID: 39420203 Free PMC article. Review.
-
Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer.Cancer Drug Resist. 2024 Sep 10;7:32. doi: 10.20517/cdr.2024.55. eCollection 2024. Cancer Drug Resist. 2024. PMID: 39403603 Free PMC article. Review.
-
Polypeptides-Based Nanocarriers in Tumor Therapy.Pharmaceutics. 2024 Sep 10;16(9):1192. doi: 10.3390/pharmaceutics16091192. Pharmaceutics. 2024. PMID: 39339228 Free PMC article. Review.
-
High infiltration of immune cells with lower immune activity mediated the heterogeneity of gastric adenocarcinoma and promoted metastasis.Heliyon. 2024 Aug 29;10(17):e37092. doi: 10.1016/j.heliyon.2024.e37092. eCollection 2024 Sep 15. Heliyon. 2024. PMID: 39319155 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources